Skip to main navigation Skip to search Skip to main content

Prevention of depression through nutritional strategies in high-risk persons: Rationale and design of the MooDFOOD prevention trial

  • Miquel Roca*
  • , Elisabeth Kohls
  • , Margalida Gili
  • , Ed Watkins
  • , Matthew Owens
  • , Ulrich Hegerl
  • , Gerard van Grootheest
  • , Mariska Bot
  • , Mieke Cabout
  • , Ingeborg A. Brouwer
  • , Marjolein Visser
  • , Brenda W. Penninx
  • , On behalf of the MooDFOOD Prevention Trial Investigators
  • *Corresponding author for this work

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Background: Obesity and depression are two prevalent conditions that are costly to individuals and society. The bidirectional association of obesity with depression, in which unhealthy dietary patterns may play an important role, has been well established. Few experimental studies have been conducted to investigate whether supplementing specific nutrients or improving diet and food-related behaviors can prevent depression in overweight persons. Method/Design: The MooDFOOD prevention trial examines the feasibility and effectiveness of two different nutritional strategies [multi-nutrient supplementation and food-related behavioral change therapy (FBC)] to prevent depression in individuals who are overweight and have elevated depressive symptoms but who are not currently or in the last 6months meeting criteria for an episode of major depressive disorder (MDD). The randomized controlled prevention trial has a two-by-two factorial design: participants are randomized to daily multi-nutrient supplement (omega-3 fatty acids, calcium, selenium, B-11 vitamin and D-3 vitamin) versus placebo, and/or FBC therapy sessions versus usual care. Interventions last 12months. In total 1000 participants aged 18-75years with body mass index between 25-40kg/m2 and with a Patient Health Questionnaire-9 score≥5 will be recruited at four study sites in four European countries. Baseline and follow-up assessments take place at 0, 3, 6, and 12months. Primary endpoint is the onset of an episode of MDD, assessed according to DSM-IV based criteria using the MINI 5.0 interview. Depressive symptoms, anxiety, food and eating behavior, physical activity and health related quality of life are secondary outcomes. During the intervention, compliance, adverse events and potentially mediating variables are carefully monitored. Discussion: The trial aims to provide a better understanding of the causal role of specific nutrients, overall diet, and food-related behavior change with respect to the incidence of MDD episodes. This knowledge will be used to develop and disseminate innovative evidence-based, feasible, and effective nutritional public health strategies for the prevention of clinical depression. Trial registration: ClinicalTrials.gov. Number of identification: NCT02529423. August 2015.

Original languageEnglish
Article number192
JournalBMC Psychiatry
Volume16
Issue number1
DOIs
Publication statusPublished - 8 Jun 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 2 - Zero Hunger
    SDG 2 Zero Hunger
  2. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Depression
  • Diet
  • Food behavior
  • Food behavioral activation
  • Multi-nutrient supplements
  • Overweight
  • Prevention
  • Randomized controlled trial

Fingerprint

Dive into the research topics of 'Prevention of depression through nutritional strategies in high-risk persons: Rationale and design of the MooDFOOD prevention trial'. Together they form a unique fingerprint.

Cite this